3D bioprinting technology

Just days after Cellink signed its latest acquisition agreement with global system supplier Ginolis, the company has announced a new takeover, this time of MatTek. A global leader of in…

Innovative biomedical company REGENHU just launched its next-generation 3D bioprinters and software as part of its ongoing mission to revolutionize medicine. Called the R-GEN series, the new systems consolidate years…

Pioneering microfluidic bioprinting company Aspect Biosystems launched a new grant program for research labs, enhancing the use of 3D bioprinting technology. The Vancouver-based biotechnology firm will choose two winners that…

At a time when experts predict cancer will remain a massive health problem, advances in technology can make a big difference. Earlier this year, the World Health Organization (WHO) announced…

For over four years biotech company Cellink has been helping researchers pursue creative ways to promote organ regeneration, test novel drugs, develop vascularized bioconstructs, and more. Through collaborative partnerships and…

Studying cancer biology is among the top priorities for researchers around the world. From consortiums to universities, pharma companies, newcomers in the drug development industry, and research institutions, current research…

In the field of 3D bioprinting, the major, overarching goal is to be able to fabricate functional 3D printed human organs. Many bioprinting companies, such as Organovo and Aether, are making…

If you are starting to get the impression that there is little researchers and innovators cannot do with 3D printing, you are thinking in the right direction—as are so many…